OECD Policy Roundtable on Risk Governance Policy for Nanotechnology - Agenda and Presentations

 

OECD Policy Roundtable on Risk Governance Policy for Nanotechnology

25 September 2009, Vienna, Austria


Hosted by the Austrian Federal Ministry for Transport, Innovation and Technology (BMVIT)

 

Agenda

 

Risk Governance Policy for Nanotechnology  - Plenary Session

 

Chair: Jacqueline Allan, Science and Technology Policy Division, OECD

 

Welcome by the OECD - Iain Gillespie, Head of the Science and Technology Policy Division, OECD
Welcome by BMVIT - Alexander Pógany, Federal Ministry for Transport, Innovation and Technology, Austria

Introductory Remarks and Outline of the Day
Jacqueline Allan
, Science and Technology Policy Division, OECD

From Risk Assessment to Risk Management: Presentation and questions by the audience
Joyce Tait, Edinburgh University, United Kingdom

Stakeholders Participation in Risk Governance for Nanotechnology: Presentation and questions by the audience 
Sergio Bellucci, Swiss Centre for Technology Assessment, Switzerland

Voluntary Measures for Risk Management : Presentation and questions by the audience 
Terry Medley, BIAC and Dupont, United States

Discussion with Speakers and Introduction to the Breakout Session

Risk Governance Policy for Nanotechnology Breakout Session

 

A short discussion paper is provided for each parallel discussion group. The paper will be introduced by means of a short presentation at the beginning of the parallel session either by the moderator of the session or by the author.

 

Group 1: The Path from Risk Assessment to Risk Management Decision Making

Moderator: Iain Gillespie, Head of the Science and Technology Policy Division, OECD

 

Presentation of the discussion paper : From Risk Assessment to Decision Making
Helge Torgersen, ITA, Austrian Academy of Sciences, Austria

Presentation 1: Rogério Gaspar, University of Lisbon, Portugal

Presentation 2:  Axel Thielmann, Fraunhofer ISI, Germany

Group Discussion

  • What are the criteria used to decide that risk management actions are required?
  • How is scientific evidence and uncertainty reflected in subsequent risk management actions?
  • How are decisions taken? - and how transparent and predictable are they?
  • To what extent is risk management science-based?

Group 2: Participatory Processes and the Involvement of Stakeholders

Moderator: André Gazsó, ITA, Austrian Academy of Sciences, Austria

 

Presentation of the discussion paper : Participation in Science and Technology
Sergio Bellucci, Swiss Centre for Technology Assessment, Switzerland

Presentation 1: Mark Dyball, People Science and Policy, United Kingdom

Presentation 2: Antje Grobe, Stiftung Risiko-Dialog, University of Stuttgart, Germany

Group Discussion

  • How do you decide to involve stakeholders in the policy process?
  • What can the participation of stakeholders add to policy making?
  • What can be achieved through participatory processes? How else might the same goals be achieved?
  • What conditions are necessary for successful participatory processes? What are the common mistakes that are made?
  • How do you evaluate the success of a participatory process?

Group 3: Voluntary Measures by Industry

Moderator: Ulrich Fiedeler, ITA, Austrian Academy of Sciences, Austria

Presentation of the discussion paper : Voluntary Measures in Nanotechnology Governance
Ulrich Fiedeler, ITA, Austrian Academy of Sciences, Austria

Presentation 1: Shaun Clancy, Evonik Degussa, United States

Presentation 2: Anna Gergely, Steptoe and Johnson, Belgium

Presentation 3: Vivian Ota Wang, National Nanotechnology Coordination Office, United States

Group Discussion

  • Are voluntary measures by industry needed? Why? Under what circumstances?
  • Who decides that voluntary measures are appropriate?
  • What alternatives to voluntary measures have been considered? Why were they not implemented?
  • How do voluntary measures fit into the overall framework for risk governance?
  • What conditions are necessary to establish voluntary measures such as industry guidelines?
  • How are successful measures developed and implemented?
  • What problems and issues (in public, industry, regulators) occur with the acceptability of guidelines and how can they be avoided or addressed?
  • Are there different national approaches and/or attitudes to voluntary measures by industry?

Risk Governance Policy for Nanotechnology - Synthesis Session

 

Chairs:
Joyce Tait, Edinburgh University, United Kingdom
Jacqueline Allan, Science and Technology Policy Division, OECD

 

Introduction by the Chairs
Group 1 Raporteur

Group 2 Raporteur

Group 3 Raporteur

Panel discussion with the speakers and moderators
Conclusions by the Chairs